What to do when a patient with exocrine pancreatic insufficiency does not respond to pancreatic enzyme substitution

Digestion

Volumn 60, Issue SUPPL. 1, 1999, Pages 97-103

  Lankisch, P G ^a  

^a Municipal Hospital of Lueneburg   (Germany)

Author keywords

Exocrine pancreatic insufficiency; H2 blockers; Lipase; Pancreatic enzyme substitution; Proton pump inhibitors

Indexed keywords

CIMETIDINE; ENZYME LEFAX; HISTAMINE H2 RECEPTOR ANTAGONIST; KREON; MICROSPHERE; PANCREAS ENZYME; PANCREAS EXTRACT; PANCREATIN; PANCRELIPASE; PANZYTRAT; PROTON PUMP INHIBITOR; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

COMPLICATION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; ENZYME ISOLATION; FAT INTAKE; HUMAN; PANCREAS EXOCRINE INSUFFICIENCY; PATIENT COMPLIANCE; PRIORITY JOURNAL; STEATORRHEA; SUBSTITUTION THERAPY;

EID: 0033023246     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051463     Document Type: Conference Paper

References (53)

1. DiMagno EP, Go VLW, Summerskill WHJ: Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973;288:813-815.
2. Regan PT, Malagelada J-R, DiMagno EP, Glanzman SL, Go VLW: Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 1977;297:854-858.
3. Drummond S, Saunders JHB, Leach R, Wormsley KG: Enzymic activities of commercial preparations of pancreatic enzymes. Scot Med J 1977;22:221-224.
4. Graham DY: Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relation between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. N Engl J Med 1977;296:1314-1317.
5. Ihse I, Lilja P: Pancreatic enzymic activities of commercial pancreatic enzyme preparations incubated in human small intestinal juice. Digestion 1979;19:48-51.
6. Ribet A, Balas D, Bommelaer G, Pradayrol L, Varignon M: Activité enzymatique 'in vitro' de différents extraits pancréatiques. Gastroenterol Clin Biol 1979;3:515-520.
7. Roberts IM: Enzyme therapy for malabsorption in exocrine pancreatic insufficiency. Pancreas 1989;4:496-503.
8. Hendeles L, Dorf A, Stecenko A, Weinberger M: Treatment failure after substitution of generic pancrelipase capsules: Correlation with in vitro lipase activity. JAMA 1990;263:2459-2461.
9. 2 test in patients with chronic pancreatitis (abstract). Digestion 1991;49:6.
10. Regan PT, DiMagno EP: Exocrine pancreatic insufficiency in celiac sprue: A cause of treatment failure. Gastroenterology 1980;78:484-487.
11. Lopez JJ, Wright JA, Hammer RA, Ertan A: Chronic pancreatitis is associated with a high prevalence of giardiasis. Can J Gastroenterol 1992;6:73-76.
12. Wright JA, Lopez J, Daum RS, Ertan A: Chronic pancreatitis is associated with a high prevalence of giardiasis (abstract). Gastroenterology 1988;94:A503.
13. Heizer WD, Cleaveland CR, Iber FL: Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 1965;116:261-270.
14. Saunders JHB, Cargill JM, Wormsley KG: Gastric secretion of acid in patients with pancreatic disease. Digestion 1978;17:365-369.
15. Gullo L, Corinaldesi R, Casadio R, Vezzadini P, Tomassetti P, Ventrucci M, Priori P, Labò G: Gastric acid secretion in chronic pancreatitis. Hepatogastroenterology 1983;30:60-62.
16. DiMagno EP, Malagelada JR, Go VLW, Moertel CG: Fate of orally ingested enzymes in pancreatic insufficiency: Comparison of two dosage schedules. N Engl J Med 1977;296:1318-1322.
17. Regan PT, Malagelada J-R, DiMagno EP, Go VLW: Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: Correction by treatment. Gastroenterology 1979;77:285-289.
18. Dutta SK, Russell RM, Iber FL: Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 1979;24:529-534.
19. Dutta SK, Russell RM, Iber FL: Impaired acid neutralization in the duodenum in pancreatic insufficiency. Dig Dis Sci 1979;24:775-780.
20. Zentler-Munro PL, Fine DR, Northfield TC: Mechanism whereby cimetidine enhances pancreatic enzyme therapy. Gastroenterology 1981;80:1323.
21. Graham DY: Pancreatic enzyme replacement: The effect of antacids or cimetidine. Dig Dis Sci 1982;27:485-490.
22. Drube HC, Büttner H: Über die Wirkung oraler Kalziumgaben auf die Stuhlfettausscheidung bei Gesunden und Kranken mit Steatorrhoe. Med Klin 1964;59:1234-1236.
23. Graham DY, Sackman JW: Mechanism of increase in steatorrhea with calcium and magnesium in exocrine pancreatic insufficiency: An animal model. Gastroenterology 1982;83:638-644.
24. DiMagno EP: Medical treatment of pancreatic insufficiency. Mayo Clin Proc 1979;54:435-442.
25. Cox KL, Isenberg JN, Osher AB, Dooley RR: The effect of cimetidine on maldigestion in cystic fibrosis. J Pediatr 1979;94:488-492.
26. Boyle BJ, Long WB, Balistreri WF, Widzer SJ, Huang N: Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis. Gastroenterology 1980;78:950-953.
27. Durie PR, Bell L, Linton W, Corey ML, Forstner GG: Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut 1980;21:778-786.
28. Lankisch PG, Lembcke B, Göke B, Creutzfeldt W: Therapy of pancreatogenic steatorrhoea: Does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 1986;24: 753-757.
29. Staub JL, Sarles H, Soule JC, Galmiche JP, Capron JP: No effect of cimetidine on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 1981;304: 1364-1365.
30. Gow R, Bradbear R, Francis P, Shepherd R: Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet 1981;ii:1071-1074.
31. DiMagno EP: Controversies in the treatment of exocrine pancreatic insufficiency. Dig Dis Sci 1982;27:481-484.
32. Freise J, Horstkotte H: Exokrine Pankreasinsuffizienz: Vergleich einer Substitutionstherapie mit nichtsäureresistenten und einer säureresistenten Enzympräparation. Fortschr Med 1986;104:625-628.
33. Stead RJ, Skypala I, Hodson ME: Treatment of steatorrhea in cystic fibrosis: A comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine. Aliment Pharmacol Ther 1988;2:471-482.
34. Stead RJ, Skypala I, Hodson ME, Batten JC: Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: Comparison with a standard enteric coated preparation. Thorax 1987;42:533-537.
35. Raimondo M, DiMagno EP: Lipolytic activity of bacterial lipase survives better than that of porcine lipase in human gastric and duodenal content. Gastroenterology 1994;107:231-235.
36. Meyer JH, Elashoff J, Porter-Fink V, Dressman J, Amidon GL: Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology 1988;94:1315-1325.
37. Mundlos S, Kühnelt P, Adler G: Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 1990;31:1324-1328.
38. Kühnelt P, Mundlos S, Adler G: Einfluss der Pelletgrösse eines Pankreascnzympräparates auf die duodenale lipolytische Aktivität. Z Gastroenterol 1991;29:417-421.
39. Layer P, Gröger G, Dicke D, v.d. Ohe M, Goebell H: Enzyme pellet size and luminal nutrient digestion in pancreatic insufficiency (abstract). Digestion 1992;52:100-101.
40. Meyer JH, Lake R: Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres. Pancreas 1997;15:226-235.
41. Bruno MJ, Borm JJJ, Hoek FJ, Delzenne B, Hofmann AF, de Goeij JJM, van Royen EA, van Leeuwen DJ, Tytgat GNJ: Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis. Dig Dis Sci 1998;43:203-213.
42. Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP: Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 1987;62:564-568.
43. Lankisch PG, Lembcke B, Kirchhoff S, Creutzfeldt W: Therapy of pancreatogenic steatorrhea: A comparison between two acid-protected enzyme preparations (abstract). Dig Dis Sci 1987;32:1174.
44. Lankisch PG, Lembcke B, Kirchhoff S, Hilgers R, Creutzfeldt W: Therapie der pankreatogenen Steatorrhoe. Dtsch Med Wochenschr 1988;113:15-17.
45. Kölbel C, Layer P, Hotz J, Goebell H: Der Einfluss eines säuregeschützten, mikroverkapselten Pankreatinpräparats auf die pankreatogene Steatorrhö. Med Klin 1986;81:85-86.
46. Zerega J, Lerner S, Meyer JH: Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency. Dig Dis Sci 1988;33:1245-1249.
47. Lembcke B, Kraus B, Lankisch PG: Small intestinal function in chronic relapsing pancreatitis. Hepatogastroenterology 1985;32:149-151.
48. Dutta SK, Anand K, Gadacz TR: Bile salt malabsorption in pancreatic insufficiency secondary to alcoholic pancreatitis. Gastroenterology 1986;91:1243-1249.
49. Layer P, Go VLW, DiMagno EP: Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol 1986;251: G475-G480.
50. Thiruvengadam R, DiMagno EP: Inactivation of human lipase by proteases. Am J Physiol 1988;255:G476-G481.
51. Mizumoto A, Koike D, Sarr MG, DiMagno EP: How important is mixing of lipase and nutrients in decreasing pancreatic steatorrhea? (abstract). Gastroenterology 1994;106:A308.
52. Chung JP, Metzger A, Asakura N, Sarr MG, DiMagno EP: Different mixing of chyme and lipolytic activity in powder and microtablet formulations of bacterial lipase during GI transit explains variable correction of canine pancreatic steatorrhea (abstract). Gastroenterology 1998;114:A448.
53. Peschke GJ: Active components and galenic aspects of enzyme preparations; in Lankisch PG (ed): Pancreatic enzymes in health and disease. Berlin, Springer, 1991, pp 55-64.